AngioDynamics CEO Jim Clemmer has spent the past two years shedding low-margin products from the Latham company's portfolio, replacing them with higher-margin emerging technology.
AngioDynamics CEO Jim Clemmer has spent the past two years shedding low-margin products from the Latham company's portfolio, replacing them with higher-margin emerging technology.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.